Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12
REDWOOD CITY, Calif., Dec. 8 (Korea Bizwire) – Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015, at 9:30 a.m. PT at the Westin St. Francis Hotel in San Francisco, [...]